Medtronic receives FDA approval for latest generation drug-eluting coronary stent system
- Friday, May 13, 2022, 7:15
- Business
- Add a comment
The Onyx Frontier™ drug-eluting stent offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent DUBLIN, May 13, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today…
About the Author
adminasapcorp has written 41608 stories on this site.